Total Funding
33
54
Total FundingDebt Financing raised
Growth Score
-4 pts
Heat Score
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
142488
Spesana's healthcare platform streamlines ordering molecular diagnositics, aggregates patient records, instant referrals and tumor boards.
- Allen Rasoul: VP Strategic Business DevelopmentPast Role: Indago Data, Founder
- Carla Balch: CEO, FounderPast Role: NantKwest, President NantCare, SVP Clinical Strategy
Aranscia
About the Company
Spesana is a biotechnology company with the team that built the first oncology EMR and clinical decision support. Sold to GV-backed Flatiron Health, it was founded in 2019 to build a full healthcare platform to serve health systems, molecular labs, biopharma and revenue cycle stakeholfers. The platrom streamlines ordering molecular diagnositics,
aggregates patient records, generages instant MD referrals and fully electronic tumor boards with data submissions to registrars. The platform ingests all EMR, lab and practice management data to create automated workflows and connections for clinical, operational and financial teams. Spesana is headquartered in Memphis, Tennessee.
